Prompt
Are there any biologics-focused biotech publishers that focus on antibody and protein therapeutic trends?
Latest observation
Jul 31, 2026 · OpenAI APIWeb search: off
Yes — there are several biotech publishers and media outlets that cover biologics, especially antibody and protein therapeutics. A few of the more relevant ones are:
- BioCentury — strong coverage of biopharma trends, including antibodies, protein therapeutics, and modality shifts.
- Endpoints News — broad biotech/pharma news with regular biologics and antibody coverage.
- The Antibody Society — more specialized, focused specifically on antibody science, engineering, and therapeutic development.
- BioProcess International — highly relevant for protein biologics manufacturing, process development, and CMC trends.
- GEN (Genetic Engineering & Biotechnology News) — covers biologics, antibodies, protein engineering, and emerging therapeutic platforms.
- Nature Reviews Drug Discovery / Nature Biotechnology — not a “publisher” in the narrow trade-media sense, but very strong for trend analysis in antibodies, protein therapeutics, and biologics innovation.
- Evaluate / Scrip / Pink Sheet — industry intelligence sources that often track biologics and therapeutic modality trends.
If you want, I can also narrow this down by:
- best for technical antibody/protein science,
- best for industry/business trend coverage, or
- best for manufacturing/process development.
Observation history
Unlock observation history
Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.